104 related articles for article (PubMed ID: 10516218)
1. Inhibition of PARS attenuates endotoxin-induced dysfunction of pulmonary vasorelaxation.
Pulido EJ; Shames BD; Selzman CH; Barton HA; Banerjee A; Bensard DD; McIntyre RC
Am J Physiol; 1999 Oct; 277(4):L769-76. PubMed ID: 10516218
[TBL] [Abstract][Full Text] [Related]
2. Cardiotrophin-1 attenuates endotoxin-induced acute lung injury.
Pulido EJ; Shames BD; Pennica D; O'leary RM; Bensard DD; Cain BS; McIntyre RC
J Surg Res; 1999 Jun; 84(2):240-6. PubMed ID: 10357926
[TBL] [Abstract][Full Text] [Related]
3. Neutrophils mediate pulmonary vasomotor dysfunction in endotoxin-induced acute lung injury.
Sheridan BC; McIntyre RC; Moore EE; Meldrum DR; Agrafojo J; Fullerton DA
J Trauma; 1997 Mar; 42(3):391-6; discussion 396-7. PubMed ID: 9095105
[TBL] [Abstract][Full Text] [Related]
4. Neutrophil depletion attenuates endotoxin-induced dysfunction of cGMP-mediated pulmonary vasorelaxation.
Sheridan BC; McIntyre RC; Agrafojo J; Meldrum DR; Meng X; Fullerton DA
Am J Physiol; 1996 Nov; 271(5 Pt 1):L820-8. PubMed ID: 8944726
[TBL] [Abstract][Full Text] [Related]
5. L-arginine prevents lung neutrophil accumulation and preserves pulmonary endothelial function after endotoxin.
Sheridan BC; McIntyre RC; Meldrum DR; Fullerton DA
Am J Physiol; 1998 Mar; 274(3):L337-42. PubMed ID: 9530168
[TBL] [Abstract][Full Text] [Related]
6. Endotoxin stuns cGMP-mediated pulmonary vasorelaxation.
Sheridan BC; McIntyre RC; Meldrum DR; Meng X; Fullerton DA
Shock; 1997 Sep; 8(3):207-12. PubMed ID: 9377168
[TBL] [Abstract][Full Text] [Related]
7. L-arginine attenuates endothelial dysfunction in endotoxin-induced lung injury.
Sheridan BC; McIntyre RC; Meldrum DR; Fullerton DA
Surgery; 1999 Jan; 125(1):33-40. PubMed ID: 9889795
[TBL] [Abstract][Full Text] [Related]
8. Dysfunction of cGMP-mediated pulmonary vasorelaxation in endotoxin-induced acute lung injury.
Fullerton DA; McIntyre RC; Hahn AR; Agrafojo J; Koike K; Meng X; Banerjee A; Harken AH
Am J Physiol; 1995 Jun; 268(6 Pt 1):L1029-35. PubMed ID: 7611425
[TBL] [Abstract][Full Text] [Related]
9. Phosphodiesterase inhibition overcomes pulmonary vasomotor dysfunction in acute lung injury.
Sheridan BC; McIntyre RC; Meldrum DR; Fullerton DA
J Surg Res; 1997 Aug; 71(2):145-9. PubMed ID: 9299282
[TBL] [Abstract][Full Text] [Related]
10. Inhibitors of poly (ADP-ribose) synthetase protect rat proximal tubular cells against oxidant stress.
Chatterjee PK; Cuzzocrea S; Thiemermann C
Kidney Int; 1999 Sep; 56(3):973-84. PubMed ID: 10469365
[TBL] [Abstract][Full Text] [Related]
11. Impairment of endothelial-dependent pulmonary vasorelaxation after mesenteric ischemia/reperfusion.
Fullerton DA; Eisenach JH; Friese RS; Agrafojo J; Sheridan BC; McIntyre RC
Surgery; 1996 Nov; 120(5):879-84. PubMed ID: 8909525
[TBL] [Abstract][Full Text] [Related]
12. Pulmonary hypertension in acute lung injury is due to impaired vasodilation with intact vascular contractility.
McIntyre RC; Banerjee A; Agrafojo J; Fullerton DA
J Surg Res; 1995 Jun; 58(6):765-70. PubMed ID: 7791358
[TBL] [Abstract][Full Text] [Related]
13. Protective effects of poly (ADP-ribose) synthase inhibitors in zymosan-activated plasma induced paw edema.
Cuzzocrea S; Costantino G; Zingarelli B; Caputi AP
Life Sci; 1999; 65(9):957-64. PubMed ID: 10465355
[TBL] [Abstract][Full Text] [Related]
14. Vinblastine attenuates endotoxin-induced impairment of CGMP-mediated pulmonary vasorelaxation.
Sheridan BC; McIntyre RC; Meldrum DR; Cleveland JC; Agrafojo J; Eisenach JH; Fullerton DA
Shock; 1996 Jul; 6(1):35-8. PubMed ID: 8828082
[TBL] [Abstract][Full Text] [Related]
15. Inhibitors of poly (ADP-ribose) synthetase protect rat cardiomyocytes against oxidant stress.
Bowes J; McDonald MC; Piper J; Thiemermann C
Cardiovasc Res; 1999 Jan; 41(1):126-34. PubMed ID: 10325960
[TBL] [Abstract][Full Text] [Related]
16. Selective inhibition of receptor-mediated pulmonary vasorelaxation in endotoxin-induced acute lung injury.
Mclntyre RC; Sheridan B; Agrafojo J; Fullerton DA
Shock; 1997 Jan; 7(1):36-41. PubMed ID: 8989834
[TBL] [Abstract][Full Text] [Related]
17. NO prevents neutrophil-mediated pulmonary vasomotor dysfunction in acute lung injury.
Friese RS; Fullerton DA; McIntyre RC; Rehring TF; Agrafojo J; Banerjee A; Harken AH
J Surg Res; 1996 Jun; 63(1):23-8. PubMed ID: 8661166
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of poly (ADP-ribose) synthetase improves pulmonary arterial endothelium-dependent relaxation after ischemic-reperfusion injury of splanchnic artery in rats.
Nagata H; Horiguchi T; Enzan K; Nishikawa T; Suzuki K
Anesth Analg; 2005 Dec; 101(6):1799-1804. PubMed ID: 16301261
[TBL] [Abstract][Full Text] [Related]
19. Pentoxifylline treatment attenuates pulmonary vasomotor dysfunction in acute lung injury.
Sheridan BC; McIntyre RC; Meldrum DR; Fullerton DA
J Surg Res; 1997 Aug; 71(2):150-4. PubMed ID: 9299283
[TBL] [Abstract][Full Text] [Related]
20. Poly(adp-ribose) synthetase inhibition reduces bacterial translocation in rats after endotoxin challenge.
Taner AS; Cinel I; Ozer L; Onde U; Taner D; Koksoy C
Shock; 2001 Aug; 16(2):159-62. PubMed ID: 11508870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
